Life Summary
Kim Eun-seok is the CEO and President of Daehwa Pharmaceutical.

He has declared the vision "Dispense in Handy," focusing on the development of improved drugs that enhance convenience for patients.

Kim was born on November 20, 1975, to Kim Soo-ji, Honorary Chairman of Daehwa Pharmaceutical, and Lee Myung-hee.

He graduated from Sungkyunkwan University with a degree in Industrial Psychology and later earned a master's degree in Business Administration from the same university.

After working at Bukwang Pharmaceutical, he joined Daehwa Pharmaceutical in 2008. In 2013, he was promoted to Executive Director.

In 2015, at the age of 40, he became the Co-CEO and President of Daehwa Pharmaceutical alongside then-Chairman Roh Byung-tae. In 2024, he was appointed as the sole CEO of Daehwa Pharmaceutical.

With 20 years of experience in the pharmaceutical industry, Kim is recognized as an expert in the field.

He has expertise in analyzing the global pharmaceutical industry and currently serves as Vice President of the Korea Pharmaceutical Traders Association.

Kim is credited with driving the growth of Daehwa Pharmaceutical by completing the construction of the second plant's Building B and advancing the Chinese business of Liporaxel Liquid, an oral anticancer drug.


#KimEunseok #DaehwaPharmaceutical #pharmaceuticalindustry #globalpharma #drugdevelopment #businessleader #Liporaxel #KoreaPharmaceuticalTradersAssociation #pharmaceuticalexpert #leadership